Press Releases – n-Lorem

GondolaBio and n-Lorem Foundation Partner to Advance Novel ASO Therapies for Genetic Diseases

Collaboration provides GondolaBio access [...]

Andrew Andrew Serrano2024-12-16T21:21:46-04:00

n-Lorem Foundation’s Nano-rare Patient Colloquium Draws More Than 750 attendees, Reinforcing Need for Treatment Options for People with Nano-rare Illnesses

n-Lorem has made tremendous [...]

Andrew Andrew Serrano2024-12-12T12:21:43-04:00

n-Lorem Foundation Has Treated 15 Nano-rare Patients and Expects to Treat More Than 25 Nano-rare Patients by Year End

n-Lorem to share its [...]

Andrew Andrew Serrano2024-10-29T17:48:00-04:00

n-Lorem Publishes Recommendations for Treating Patients with Heterozygous Toxic Gain of Function Mutations

Article published in Nucleic [...]

Andrew Andrew Serrano2024-12-16T20:03:25-04:00

AdventHealth for Children Collaborating with n-Lorem Foundation to Provide Personalized Treatments to Patients with Nano-rare Genetic Diseases

[...]

Andrew Andrew Serrano2024-12-12T12:15:28-04:00

Positive Clinical Observations from n-Lorem Treated, KIF1A Nano-rare Patient Published in Nature Medicine

Case study, published in [...]

Andrew Andrew Serrano2024-10-29T17:35:56-04:00

CYTIVA PRESS RELEASE: Cytiva continues its support for n-Lorem Foundation

Donation will assist in [...]

Andrew Andrew Serrano2024-10-02T19:28:54-04:00

n-Lorem Foundation Names Andrew W. Lo as a New Member of its Board of Directors

Andrew Lo’s expertise in [...]

Andrew Andrew Serrano2024-08-13T21:09:50-04:00

n-Lorem Foundation Welcomes New Member Alan Lotvin to its Board of Directors

Alan Lotvin’s expertise in [...]

Andrew Andrew Serrano2024-08-13T21:09:24-04:00

n-Lorem Foundation Partners with Hongene Biotech Corporation to Support the Discovery of Personalized ASO Medicines for Nano-rare Patients

SAN DIEGO, Calif., [...]

Andrew Andrew Serrano2024-08-26T21:00:19-04:00